Research and innovation in new device
The LiMAx liver function measurement device has been developed for the special use in the surgical field. The LiMAx-Test has already been used in a wide range of clinical questions in numerous clinics, e.g. in patients with liver cancer.
Because the long-term and non-invasive monitoring of patients with chronic liver diseases is essential to optimise the patient care, the goal of this funded project, as part of the Pro FIT program, is to reshape current version of the device and extend its use in general healthcare, releasing the full potential of the LiMAx test.
The focus of this development project is to extend the use of the LiMAx test in several new indications to assist medical professionals to face the clinical challenges.
In addition, the manufacturing of the equipment will be simplified to prepare for the growing demand from the market and to keep our innovation centre in Berlin.
The expected result of this project is a CE-certified small series of the expanded product portfolio of Humedics GmbH.
This project has been co-financed by the European Regional Development Fund (ERDF).
Investigator initiated research: Collaborate with Humedics to help patients suffering from liver diseases
More than 100 million people world-wide suffer from liver diseases (i.e. cirrhosis, hepatitis, fatty liver, metabolic disorders and liver tumors). Humedics actively supports investigator initiated research on Humdecis´marketed products or within our therapeutic areas of interest. This research is intended to improve treatment outcomes of patients suffering from liver diseases and contributes knowledge to the medical community.
Our areas of interest are:
- Primary liver cancer
- Colorectal liver metastasis
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
This global program is open to all researchers who are interested in conducting their own research. Private investigators can collaborate with Humedics to develop clinical programs. Depending on the type of research, Humedics may provide flexible funding to support clinical development activities.